Document:

Exhibit 10.1

 

SECURITIES
PURCHASE AGREEMENT

 

This Securities Purchase
Agreement (this “Agreement”) is dated as of May 12, 2021, between Theralink Technologies, Inc., a Nevada corporation
(the “Company”), and each investor identified on the signature pages to this Agreement (each a “Purchaser”).

 

WHEREAS, the Company
is seeking to raise a maximum of $4 million (the “Maximum”) in an offering of Notes (as defined below) and
Warrants (as defined below) to investors (including the Purchaser) (the “Offering”);

 

WHEREAS, the Investor
desires to purchase from the Company a convertible secured promissory note, in the form attached hereto as Exhibit A (each
a “Note” and collectively, the “Notes”), which Note shall be convertible into the Company’s
common stock, par value $0.0001 per share (the “Common Stock”), in accordance with its terms and the Note shall
be secured in accordance with the terms set forth in a security agreement between the Company and the Purchaser in the form attached
hereto as Exhibit B (each a “Security Agreement”);

 

WHEREAS, in connection
with the Offering, the Company will issue warrants to purchase shares of Common Stock in an amount equal to 20% of the number
of the total shares of Common Stock convertible under the Note (such shares, the “Warrant Shares”), in the
form attached hereto as Exhibit C (each a “Warrant”);

 

WHEREAS, subject to the
terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section 5
of the Securities Act contained in Section 4(a)(2) thereof and/or Rule 506(b) thereunder, the Company desires to issue and sell
to the Purchaser, and the Purchaser desires to purchase from the Company, the Note in the Offering as more fully described in
this Agreement.

 

NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of
which are hereby acknowledged, the Company and the Purchaser agree as follows:

 

ARTICLE I.

DEFINITIONS

 

1.1       Definitions.
In addition to the words and terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:

 

“Action”
shall have the meaning ascribed to such term in Section 3.1(j).

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person as such terms are used in and construed under Rule 405 under the Securities Act.

 

“Board of Directors”
means the board of directors of the Company.

 

“Business Day”
means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which
banking institutions in the State of New York are authorized or required by law or other governmental action to close.

 

“Certificates”
means the stock certificates evidencing the Shares which the Purchaser is purchasing hereunder registered in the name of such
Purchaser.

 

“Closing”
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.

 

“Closing Date”
means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto,
and all conditions precedent to (i) the Purchaser’s obligations to pay the Subscription Amount and (ii) the Company’s
obligations to deliver the Notes and Warrants to be issued and sold, in each case, have been satisfied or waived, but in no event
later than the second Trading Day following the date hereof.

 

    	 

    	 

    

 

“Common Stock”
means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such securities
may hereafter be reclassified or changed.

 

“Common Stock
Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive,
Common Stock.

 

“Company Counsel”
means K&L Gates LLP.

 

“Developer”
shall have the meaning ascribed to such term in Section 3.1(p).

 

“Developer Agreements”
shall have the meaning ascribed to such term in Section 3.1(p).

 

“Disqualification
Event” shall have the meaning ascribed to such term in Section 3.1(ff).

 

“Environmental
Laws” shall have the meaning ascribed to such term in Section 3.1(m).

 

“Exchange Act”
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“FCPA”
means the Foreign Corrupt Practices Act of 1977, as amended.

 

“GAAP”
shall have the meaning ascribed to such term in Section 3.1(h).

 

“Hazardous Materials”
shall have the meaning ascribed to such term in Section 3.1(m).

 

“Intellectual
Property” means all of the following in any jurisdiction throughout the world: (a) all inventions (whether patentable
or unpatentable and whether or not reduced to practice), all improvements thereto, and all U.S. and foreign patents, patent applications,
and patent disclosures, together with all reissuances, continuations, continuations-in-part, revisions, extensions, and reexaminations
thereof, (b) all trademarks, service marks, brand names, certification marks, trade dress, logos, trade names, domain names, assumed
names and corporate names, together with all colorable imitations thereof, and including all goodwill associated therewith, and
all applications, registrations, and renewals in connection therewith, (c) all copyrights, and all applications, registrations,
and renewals in connection therewith, (d) all trade secrets under applicable state laws and the common law and know-how (including
formulas, techniques, technical data, designs, drawings, specifications, customer and supplier lists, pricing and cost information,
and business and marketing plans and proposals), (e) all computer software (including source code, object code, diagrams, data
and related documentation), and (f) all copies and tangible embodiments of the foregoing (in whatever form or medium).

 

“Intellectual
Property Agreements” shall have the meaning ascribed to such term in Section 3.1(p).

 

“Issuer Covered
Persons” shall have the meaning ascribed to such term in Section 3.1(ff).

 

“Legend Removal
Date” shall have the meaning ascribed to such term in Section 4.1(c).

 

“Licensed Intellectual
Property Agreement” shall have the meaning ascribed to such term in Section 3.1(p).

 

“Liens”
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

“Material Adverse
Effect” shall have the meaning assigned to such term in Section 3.1(b).

 

“Material Permits”
shall have the meaning ascribed to such term in Section 3.1(n).

 

    	 

    	 

    

 

“OFAC”
means the Office of Foreign Assets Control of the U.S. Treasury Department.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial
proceeding, such as a deposition), whether commenced or threatened.

 

“Regulation FD”
means Regulation FD promulgated by the SEC pursuant to the Exchange Act, as such Regulation may be amended or interpreted from
time to time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect
as such Regulation.

 

“Required Approvals”
shall have the meaning ascribed to such term in Section 3.1(e).

 

“Required Minimum”
means, as of any date, the maximum aggregate number of shares of Common Stock then issued or potentially issuable in the future
pursuant to the Transaction Documents, including any Shares issuable upon conversion and exercise of the Notes and Warrants, respectively,
ignoring any exercise limits set forth therein.

 

“Rule 144”
means Rule 144 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended or interpreted from time to
time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such
Rule.

 

“SEC”
means the United States Securities and Exchange Commission.

 

“SEC Reports”
shall have the meaning ascribed to such term in Section 3.1(h).

 

“Securities”
means the Note, the Warrant, the Conversion Shares and the Warrant Shares.

 

“Securities Act”
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Shares”
means the Common Stock issuable upon conversion or exercise of the Notes and the Warrants, respectively.

 

“Short Sales”
means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to
include the location and/or reservation of borrowable shares of Common Stock).

 

“Subscription
Amount” means, as to the Purchaser, the aggregate amount to be paid for the Notes purchased hereunder as specified below
the Purchaser’s name on the signature page of this Agreement and next to the heading “Subscription Amount,”
in United States dollars and in immediately available funds.

 

“Subsidiary”
means with respect to any entity at any date, any direct or indirect corporation, limited or general partnership, limited liability
company, trust, estate, association, joint venture or other business entity of which (A) more than 50% of (i) the outstanding
capital stock having (in the absence of contingencies) ordinary voting power to elect a majority of the board of directors or
other managing body of such entity, (ii) in the case of a partnership or limited liability company, the interest in the capital
or profits of such partnership or limited liability company or (iii) in the case of a trust, estate, association, joint venture
or other entity, the beneficial interest in such trust, estate, association or other entity business is, at the time of determination,
owned or controlled directly or indirectly through one or more intermediaries, by such entity, or (B) is under the actual control
of the Company.

 

“Trading Day”
means a day on which the principal Trading Market is open for trading.

 

“Trading Market”
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question:
the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange,
the OTCQB, the OTCQX, or the OTC Pink Marketplace (or any successors to any of the foregoing).

 

    	 

    	 

    

 

“Transaction
Documents” means this Agreement, the Notes, the Security Agreement, the Warrants and any other documents or agreements
executed in connection with the transactions contemplated hereunder.

 

“Transfer Agent”
means West Coast Stock Transfer, Inc., 721 N. Vulcan Ave, Suite 205. Encinitas, CA 92024, and any successor transfer agent of
the Company.

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then
listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if prices for the Common Stock are
then reported on the OTC Pink Marketplace maintained by the OTC Markets Group, Inc. (or a similar organization or agency succeeding
to its functions of reporting prices), the volume weighted average price of the Common Stock on the first such facility (or a
similar organization or agency succeeding to its functions of reporting prices), or (c) in all other cases, the fair market value
of a share of Common Stock as determined by the Board of Directors of the Company.

 

ARTICLE II.

PURCHASE AND SALE

 

2.1       Closing.
On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution
and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchaser agrees to purchase the amount
of Notes as is set forth opposite such Purchaser’s name on the Purchaser’s signature page. The Purchaser shall deliver
to the Company, via wire transfer immediately available funds equal to the Purchaser’s Subscription Amount as set forth
on the signature page hereto executed by the Purchaser, and the Company and the Purchaser shall deliver the other items set forth
in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3,
the Closing shall occur at the offices of Company Counsel or such other location as the parties shall mutually agree. In no event
will the Company raise more than the Maximum from the sale of the Notes.

 

2.2       Deliveries.

 

(a)       On
or prior to Closing Date, the Company shall deliver or cause to be delivered to the Purchaser the following:

 

(i)       this
Agreement duly executed by the Company;

 

(ii)       the
Note duly executed by the Company;

 

(iii)       the
Security Agreement duly executed by the Company;

 

(iv)       the
Warrant duly executed by the Company; and

 

(v)       a
Board Consent approving the issuance of the Notes, the Warrants, the Security Agreement and the Shares and the execution of the
Transaction Documents on behalf of the Company.

 

(b)       On
or prior to the Closing Date the Purchaser shall deliver or cause to be delivered to the Company the following:

 

(i)       this
Agreement duly executed by the Purchaser;

 

(ii)       the
Note duly executed by the Purchaser;

 

    	 

    	 

    

 

(iii)       the
Security Agreement duly executed by the Purchaser; and

 

(iv)       the
Purchaser’s Subscription Amount by wire transfer to the Company.

 

2.3       Closing
Conditions.

 

(a)       The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:

 

(i)       the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) on the Closing Date of the representations and warranties of the Purchaser contained herein (unless as
of a specific date therein in which case they shall be accurate as of such date);

 

(ii)       all
obligations, covenants and agreements of the Purchaser required to be performed at or prior to the Closing Date shall have been
performed;

 

(iii)       the
delivery by the Purchaser of the items set forth in Section 2.2(b) of this Agreement;

 

(b)       The
respective obligations of the Purchaser hereunder in connection with the Closing are subject to the following conditions being
met:

 

(i)       the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein
(unless as of a specific date therein);

 

(ii)       all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been
performed;

 

(iii)       the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;

 

(iv)       there
shall have been no Material Adverse Effect with respect to the Company since the date hereof; and

 

(v)       from
the date hereof to the Closing Date trading in the Common Stock shall not have been suspended by the SEC or the Company’s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg
L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are
reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States
or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national
or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in
each case, in the reasonable judgment of the Purchaser, makes it impracticable or inadvisable to purchase the Notes and Warrants
at the Closing.

 

    	 

    	 

    

 

ARTICLE III.

REPRESENTATIONS AND WARRANTIES

 

3.1       Representations
and Warranties of the Company. The Company hereby makes the following representations and warranties to the Purchaser as of the
date hereof:

 

(a)       Subsidiaries.
All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding
shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar
rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or
any of them in the Transaction Documents shall be disregarded. The Subsidiaries are listed on Schedule 3.1(a).

 

(b)       Organization
and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly
existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company
nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation,
bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business
and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted
or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as
the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity
or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business,
prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse
effect on the Company’s ability to perform in any material respect on a timely basis its obligations under any Transaction
Document (any of (i), (ii) or (iii), a “Material Adverse Effect”) and no Proceeding has been instituted in
any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

 

(c)       Authorization;
Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder
and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the
consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the
part of the Company and no further action is required by the Company, the Board of Directors or the Company’s stockholders
in connection herewith or therewith other than in connection with the Required Approvals. Subject to obtaining the Required Approvals,
this Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed
by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation
of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles
and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.

 

(d)       No
Conflicts. Except as set forth in Schedule 3.1(d), the execution, delivery and performance by the Company of this Agreement
and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it
of the transactions contemplated hereby and thereby do not and will not (i) subject to the Required Approvals, conflict with or
violate any provision of the Company’s or any Subsidiary’s certificate or articles of incorporation, bylaws or other
organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of
time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company
or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice,
lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or
otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company
or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of
any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to
which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property
or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could
not have or reasonably be expected to result in a Material Adverse Effect.

 

    	 

    	 

    

 

(e)       Filings,
Consents and Approvals. Except as set forth on Schedule 3.1(e), the Company is not required to obtain any consent,
waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state,
local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company
of the Transaction Documents, other than: (i) the filings required pursuant to Section 4.4 of this Agreement, (ii) application(s)
to each applicable Trading Market for the listing of the Shares for trading thereon in the time and manner required thereby, (iii)
such filings as are required to be made under applicable state securities laws and (iv) the consent of the necessary holders of
the Series C-1, Series C-2 and Series E Convertible Preferred Stock of the Company (each of (i) thorough (iv) are the “Required
Approvals”).

 

(f)       Issuance
of the Securities. The Shares, when issued upon conversion or exercise of the Notes and Warrants, respectively, will be validly
issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company shall reserve from its duly
authorized capital stock a number of shares of Common Stock issuable pursuant to the Notes and Warrants equal to the amount set
forth in Section 4.9. Notwithstanding the foregoing, no shares of Common Stock may be issued by the Company upon conversion of
the Notes or pursuant to the Warrants until such time as the Company is current in its reporting obligations with the SEC and
upon the CUSIP eligibility of such shares of Common Stock.

 

(g)       Capitalization.
The capitalization of the Company is as set forth on Schedule 3.1(g). Except as set forth in the SEC Reports, as a result
of the purchase and sale of the Securities or as set forth on Schedule 3.1(g), there are no outstanding options, warrants,
scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations
convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of
Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company
or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock
of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of
Common Stock or other securities to any Person (other than the Purchaser) and will not result in a right of any holder of Company
securities to adjust the exercise, conversion, exchange or reset price under any of such securities. There are no outstanding
securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no
contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem
a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or “phantom stock”
plans or agreements or any similar plan or agreement. No further approval or authorization of any stockholder, the Board of Directors
or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or
other similar agreements with respect to the Company’s capital stock to which the Company is a party or, to the knowledge
of the Company, between or among any of the Company’s stockholders.

 

    	 

    	 

    

 

(h)       SEC
Reports; Financial Statements. The Company has not filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof
since June 30, 2020 (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein,
being collectively referred to herein as the “SEC Reports”). Prior to June 30, 2020, as of their respective
dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as
applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading. The financial statements of the Company included in the SEC Reports filed prior to June
30, 2020 comply in all material respects with applicable accounting requirements and the rules and regulations of the SEC with
respect thereto as in effect at the time of filing. Except as set forth on Schedule 3.1(h), such financial statements have
been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the
periods involved (“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto
and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material
respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results
of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial,
year-end audit adjustments.

 

(i)       Material
Changes; Undisclosed Events, Liabilities or Developments. Except as set forth on Schedule 3.1(i), since the date of
the latest audited financial statements included within the SEC Reports, except as specifically disclosed in a subsequent SEC
Report filed prior to the date hereof, (i) there has been no event, occurrence or development that has had or that could reasonably
be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise)
other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and
(B) liabilities not required to be reflected in the Company’s financial statements pursuant to GAAP or disclosed in filings
made with the SEC, (iii) the Company has not altered its method of accounting, and (iv) the Company has not declared or made any
dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase
or redeem any shares of its capital stock. The Company does not have pending before the SEC any request for confidential treatment
of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth on Schedule 3.1(i),
no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or
exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets
or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this
representation is made or deemed made that has not been publicly disclosed at least one Trading Day prior to the date that this
representation is made.

 

(j)       Litigation.
There is no action, suit, inquiry, notice of violation, proceeding or investigation, inquiry or other similar proceeding of any
federal or state government unit pending or, to the knowledge of the Company, threatened against or affecting the Company, any
Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or
regulatory authority (federal, state, county, local or foreign) (collectively, an “Action”) which (i) adversely
affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the issuance of the Securities
or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. The
Company has no reason to believe that an Action will be filed against it in the future. Neither the Company nor any Subsidiary,
nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under
federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company,
there is not pending or contemplated, any investigation by the SEC involving the Company or any current or former director or
officer of the Company. The SEC has not issued any stop order or other order suspending the effectiveness of any registration
statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act, and the Company has no reason to
believe it will do so in the future.

 

    	 

    	 

    

 

(k)       Labor
Relations. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of
the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’
employees is a member of a union that relates to such employee’s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries
believe that their relationships with their employees are good. To the knowledge of the Company, no effort is underway to unionize
or organize the employees of the Company or any Subsidiary. To the knowledge of the Company, no executive officer of the Company
or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality,
disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive
covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company
or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are
in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices,
terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or
in the aggregate, reasonably be expected to have a Material Adverse Effect. There is no workmen’s compensation liability
matter, employment-related charge, complaint, grievance, investigation, inquiry or obligation of any kind pending, or to the Company’s
knowledge, threatened, relating to an alleged violation or breach by the Company or its Subsidiaries of any law, regulation or
contract that could, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

(l)       Compliance.
Except as set forth on Schedule 3.1(l), neither the Company nor any Subsidiary: (i) is in default under or in violation
of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by
the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under
or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party
or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation
of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation
of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal,
state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and
employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse
Effect.

 

(m)       Environmental
Laws. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface
strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants,
or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise
relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials,
as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice
letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (“Environmental Laws”);
(ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their
respective businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where
in each clause (i), (ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate,
a Material Adverse Effect.

 

(n)       Regulatory
Permits. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (“Material
Permits”), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation
or modification of any Material Permit.

 

(o)       Title
to Assets. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not
materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries, and (ii)
Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with
GAAP and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease
by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and
the Subsidiaries are in compliance.

 

    	 

    	 

    

 

(p)       Intellectual
Property.

 

(i)       The
Company owns or possesses or has the right to use pursuant to a valid and enforceable written license, sublicense, agreement,
or permission all Intellectual Property necessary for the operation of the business of the Company as presently conducted. The
Company has provided the Purchaser a true and complete copy of each such written license, sublicense, agreement or permission.

 

(ii)       The
Intellectual Property does not interfere with, infringe upon, misappropriate, or otherwise come into conflict with, any Intellectual
Property rights of third parties, and the Company has no Knowledge that facts exist which indicate a likelihood of the foregoing.
The Company has not received any charge, complaint, claim, demand, or notice alleging any such interference, infringement, misappropriation,
or conflict (including any claim that the Company must license or refrain from using any Intellectual Property rights of any third
party). To the Knowledge of the Company, no third party has interfered with, infringed upon, misappropriated, or otherwise come
into conflict with, any Intellectual Property rights of the Company.

 

(iii)       The
Company has no pending patent applications or applications for registration that either entity has made with respect to any Intellectual
Property. Schedule 3.1(p) identifies each license, sublicense, agreement, or other permission that the Company has granted
to any third party with respect to any of such Intellectual Property (together with any exceptions). The Company has delivered
to the Purchaser correct and complete copies of all such licenses, sublicenses, agreements, and permissions (as amended to date)
(“Intellectual Property Agreements”). Schedule 3.1(p) also identifies each registered and unregistered
trademark, service mark, trade name, corporate name, URLs or Internet domain name used by the Company in connection with its business
and which is not licensed from a third party. With respect to each item of Intellectual Property required to be identified in
Schedule 3.1(p):

 

		(A)	The Company owns and possesses
                                         all right, title, and interest in and to the item, free and clear of any Lien, license,
                                         or other restriction or limitation regarding use or disclosure;

 

		(B)	The item is not subject to any
                                         outstanding injunction, judgment, order, decree, ruling, or charge;

 

		(C)	No Action, claim, or demand is
                                         pending or, to the knowledge of the Company, is threatened that challenges the legality,
                                         validity, enforceability, use, or ownership by the Company; and

 

		(D)	The Company has not agreed to
                                         indemnify any Person for or against any interference, infringement, misappropriation,
                                         or other conflict with respect to the item.

 

(iv)       Schedule
3.1(p)(iv) identifies each item of Intellectual Property that any third party owns and that the Company uses pursuant to license,
sublicense, agreement, or permission, excluding off-the-shelf software purchased or licensed by the Company. The Company has delivered
to the Purchaser correct and complete copies of all such licenses, sublicenses, agreements, and permissions (each as amended to
date) (each, a “Licensed Intellectual Property Agreement”). With respect to each Licensed Intellectual Property
Agreement:

 

		(A)	The Licensed Intellectual Property
                                         Agreement is legal, valid, binding, enforceable, and in full force and effect;

 

    	 

    	 

    

 

		(B)	No party to the Licensed Intellectual
                                         Property Agreement is in breach or default, and no event has occurred that with notice
                                         or lapse of time would constitute a breach or default or permit termination, modification,
                                         or acceleration thereunder, which as to any such breach, default or event could have
                                         a Material Adverse Effect on the Company;

 

		(C)	No party to such Licensed Intellectual
                                         Property Agreement has repudiated any provision thereof;

 

		(D)	Except as set forth in such Licensed
                                         Intellectual Property Agreement, the Company has not received written or verbal notice
                                         or otherwise has Knowledge that the underlying item of Intellectual Property is subject
                                         to any outstanding injunction, judgment, order, decree, ruling, or charge; and

 

		(E)	Except as set forth on Schedule
                                         3.1(p)(iv), the Company has not granted any sublicense or similar right with respect
                                         to the license, sublicense, agreement, or permission.

 

(v)       The
Company has complied with and is presently in compliance with all foreign, federal, state, local, governmental (including, but
not limited to, the Federal Trade Commission and State Attorneys General), administrative, or regulatory laws, regulations, guidelines,
and rules applicable to any personal identifiable information.

 

(vi)       Each
Person who participated in the creation, conception, invention or development of the Intellectual Property currently used in the
business of the Company (each, a “Developer”) which is not licensed from third parties has executed one or
more agreements containing industry standard confidentiality, work for hire and assignment provisions, whereby the Developer has
assigned to the Company all copyrights, patent rights, Intellectual Property rights and other rights in the Intellectual Property,
including all rights in the Intellectual Property that existed prior to the assignment of rights by such Person to the Company.
The Company has provided to the Purchaser copies of any such agreements and assignments from each such Developer (collectively,
the “Developer Agreements”).

 

(vii)       Each
Developer has signed a perpetual non-disclosure agreement with the Company. The Company has provided, or will provide prior to
Closing, to the Purchaser copies any such non-disclosure agreements from each such Person, if any.

 

(q)       Insurance.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks
and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged. Neither
the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as
and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business
without a significant increase in cost.

 

(r)       Transactions
With Affiliates and Employees. Except as set forth in the SEC Reports or as a result of the transactions contemplated hereby,
none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees
of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services
as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of
services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or
lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of
the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director,
trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting
fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits,
including stock award agreements under any equity incentive plan of the Company.

 

    	 

    	 

    

 

(s)       Certain
Fees. No brokerage or finder’s fees or commissions are or will be payable by the Company or any Subsidiary to any broker,
financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions
contemplated by the Transaction Documents. The Purchaser shall have no obligation with respect to any fees or with respect to
any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection
with the transactions contemplated by the Transaction Documents.

 

(t)       Investment
Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will
not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940, as
amended. The Company shall conduct its business in a manner so that it will not become an “investment company” subject
to registration under the Investment Company Act of 1940, as amended.

 

(u)       Registration
Rights. Except as set forth on Schedule 3.1(u), no Person has any right to cause the Company or any Subsidiary to effect
the registration under the Securities Act of any securities of the Company or any Subsidiary except as disclosed on Schedule
3.1(u).

 

(v)       Listing
and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the
Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the SEC is contemplating terminating
such registration. The Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company
is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing
and maintenance requirements.

 

(w)       Application
of Takeover Protections. The Company and the Board of Directors have taken all necessary action, if any, in order to render
inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company’s certificate of incorporation (or similar charter documents)
or the laws of its state of incorporation that is or could become applicable to the Purchaser as a result of the Purchaser and
the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation
as a result of the Company’s issuance of the Securities and the Purchaser’s ownership of the Securities.

 

(x)       No
Integrated Offering. Assuming the accuracy of the Purchaser’s representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made
any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering
of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions
of any Trading Market on which any of the securities of the Company are listed or designated.

 

(y)       Tax
Status. Except for matters that would not individually have or reasonably be expected to result in a Material Adverse Effect,
the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign
income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid
all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns,
reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes
for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know
of no basis for any such claim.

 

    	 

    	 

    

 

(z)       Foreign
Corrupt Practices. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent
or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any
unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns
from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person
acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated any provision of FCPA.

 

(aa)       Acknowledgment
Regarding Purchaser’s Purchase of Securities. The Company acknowledges and agrees that the Purchaser is acting solely
in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in
any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given
by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions
contemplated thereby is merely incidental to the Purchaser’s purchase of the Securities. The Company further represents
to the Purchaser that the Company’s decision to enter into this Agreement and the other Transaction Documents has been based
solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.

 

(bb)       Acknowledgement
Regarding Purchaser’s Trading Activity. Notwithstanding anything in this Agreement or elsewhere to the contrary (except
for Sections 3.2(f) and 4.13 hereof), it is understood and acknowledged by the Company that: (i) the Purchaser has not been asked
by the Company to agree, nor has the Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of
the Company, or “derivative” securities based on securities issued by the Company or to hold the Securities for any
specified term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation,
Short Sales or “derivative” transactions, before or after the closing of this or future private placement transactions,
may negatively impact the market price of the Company’s publicly-traded securities; (iii) any Purchaser, and counter-parties
in “derivative” transactions to which the Purchaser is a party, directly or indirectly, presently may have a “short”
position in the Common Stock, and (iv) the Purchaser shall not be deemed to have any affiliation with or control over any arm’s
length counter-party in any “derivative” transaction. The Company further understands and acknowledges that
(y) the Purchaser may engage in hedging activities at various times during the period that the Securities are outstanding, and
(z) such hedging activities (if any) could reduce the value of the existing stockholders’ equity interests in the Company
at and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging
activities do not constitute a breach of any of the Transaction Documents.

 

(cc)        Regulation
M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting
purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase
any other securities of the Company.

 

(dd)        Private
Placement. Assuming the accuracy of the Purchaser’s representations and warranties set forth in Section 3.2, no registration
under the Securities Act is required for the offer and sale of the Securities.

 

(ee)        No General
Solicitation. Neither the Company nor any person acting on behalf of the Company has offered or sold any of the Securities
by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchaser
and certain other “accredited investors” within the meaning of Rule 501 under the Securities Act.

 

    	 

    	 

    

 

 

(ff)        No
Disqualification Events. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506(b) under
the Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other
officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company’s outstanding
voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under
the Securities Act) connected with the Company in any capacity at the time of sale, nor any Person, including a placement agent,
who will receive a commission or fees for soliciting purchasers (each, an “Issuer Covered Person” and, together,
“Issuer Covered Persons”) is subject to any of the “Bad Actor” disqualifications described in Rule
506(d)(1)(i) to (viii) under the Securities Act (a “Disqualification Event”), except for a Disqualification
Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person
is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under
Rule 506(e), and has furnished to the Purchaser a copy of any disclosures provided thereunder.

 

(gg)        Notice
of Disqualification Events. The Company will notify the Purchaser in writing, prior to the Closing Date of (i) any Disqualification
Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably be expected to
become a Disqualification Event relating to any Issuer Covered Person, in each case of which it is aware.

 

(hh)        Non-Affiliates.
The Company hereby acknowledges that the Purchasers, other than Doug Mergenthaler, are not and will not be upon closing of this
Agreement be deemed an “affiliate” as defined in Rule 144 nor will the Purchasers be deemed a “group”
(as described in Rule 13d-5(b)(1) promulgated under the 1934 Act). The Company will not to take any action such that the Purchasers
will be deemed to be affiliates.

 

(ii)       U.S.
Real Property Holding Corporation. The Company is not and has never been a U.S. real property holding corporation within the
meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser’s
request.

 

3.2       Representations
and Warranties of the Purchaser. The Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein):

 

(a)       Organization;
Authority. The Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability
company or similar power and authority to enter into and to consummate the transactions contemplated by this Agreement and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and performance by the Purchaser
of the transactions contemplated by this Agreement have been duly authorized by all necessary corporate, partnership, limited
liability company or similar action, as applicable, on the part of the Purchaser. Each Transaction Document to which it is a party
has been duly executed by the Purchaser, and when delivered by the Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of the Purchaser, enforceable against it in accordance with its terms, except: (i) as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of
specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions
may be limited by applicable law.

 

    	 

    	 

    

 

(b)       Understandings
or Arrangements. The Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect
arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation
and warranty not limiting the Purchaser’s right to sell the Securities in compliance with applicable federal and state securities
laws). The Purchaser is acquiring the Securities hereunder in the ordinary course of its business. The Purchaser understands that
the Securities are “restricted securities” and have not been registered under the Securities Act or any applicable
state securities law and is acquiring such Securities as principal for its own account and not with a view to or for distributing
or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has
no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities
law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution
of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty
not limiting the Purchaser’s right to sell such Securities in compliance with applicable federal and state securities laws).

 

(c)       Purchaser
Status. At the time the Purchaser was offered the Securities, it was, and as of the date hereof it is, an accredited investor
within the meaning of Rule 501 under the Securities Act. No Purchaser is subject to any of the “Bad Actor” disqualifications
described in Rule 506(d)(1)(i) to (viii) under the Securities Act, except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3).

 

(d)       Experience
of the Purchaser. The Purchaser, either alone or together with its representatives, has such knowledge, sophistication and
experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. The Purchaser is able to bear the economic risk
of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.

 

(e)       Access
to Information. The Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded, subject to Regulation FD, (i) the opportunity to
ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms
and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information
about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient
to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses
or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to
the investment. The Purchaser acknowledges and agrees that neither the Company nor anyone else has provided the Purchaser with
any information or advice with respect to the Securities nor is such information or advice necessary or desired.

 

(f)       Certain
Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, the Purchaser has not,
nor has any Person acting on behalf of or pursuant to any understanding with the Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that the
Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting
forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding
the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage
separate portions of the Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions
made by the portfolio managers managing other portions of the Purchaser’s assets, the representation set forth above shall
only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase
the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to the Purchaser’s representatives,
including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates,
the Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including
the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance of doubt, nothing contained herein
shall constitute a representation or warranty, or preclude any actions, with respect to the identification of the availability
of, or securing of, available shares to borrow in order to effect Short Sales or similar transactions in the future.

 

    	 

    	 

    

 

The Company acknowledges and agrees that the
representations contained in this Section 3.2 shall not modify, amend or affect the Purchaser’s right to rely on the Company’s
representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction
Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of
the transaction contemplated hereby.

 

ARTICLE IV.

OTHER AGREEMENTS OF THE PARTIES

 

4.1       Removal
of Legends.

 

(a)       The
Securities may only be disposed of in compliance with state and federal securities laws, including for estate planning purposes.
In connection with any transfer of Securities other than pursuant to an effective registration statement or Rule 144, to the Company
or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company at its sole cost
may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable
to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such
transfer does not require registration under the Securities Act.

 

(b)       The
Purchaser agrees to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following
form:

 

NEITHER THIS SECURITY NOR THE SECURITIES INTO
WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF
THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH
A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER
LOAN SECURED BY SUCH SECURITIES.

 

The Company acknowledges
and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer
or grant a security interest in some or all of the Securities to a financial institution that is an “accredited investor”
as defined in Rule 501(a) under the Securities Act and who agrees to be bound by the provisions of this Agreement and, if required
under the terms of such arrangement, the Purchaser may transfer pledged or secured Securities to the pledgees or secured parties.
Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee,
secured party or pledgor shall be required in connection therewith. Further, no notice shall be required of such pledge. At the
appropriate Purchaser’s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured
party of Securities may reasonably request in connection with a pledge or transfer of the Securities.

 

    	 

    	 

    

 

(c)       Certificates
evidencing the Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof): (i) while a registration
statement covering the resale of such Shares is effective under the Securities Act, (ii) following any sale of such Shares pursuant
to Rule 144, (iii) if such Shares are eligible for sale under Rule 144, without the requirement for the Company to be in compliance
with the current public information required under Rule 144 as to such Shares and without volume or manner-of-sale restrictions
or (iv) if such legend is not required under applicable requirements of the Securities Act (including Section 4(a)(1), judicial
interpretations and pronouncements issued by the staff of the SEC) (the “Effective Date”). The Company shall,
at its expense, cause its counsel to issue a legal opinion to the Transfer Agent promptly after the Effective Date if required
by the Transfer Agent to effect the removal of the legend hereunder. If all or any portion of Shares are converted at a time when
there is an effective registration statement to cover the resale of the Shares, or if such Shares may be sold under Rule 144 and
the Company is then in compliance with the current public information required under Rule 144, or if the Shares may be sold under
Rule 144 without the requirement for the Company to be in compliance with the current public information required under Rule 144
as to such Shares and without volume or manner-of-sale restrictions or if such legend is not otherwise required under applicable
requirements of the Securities Act (including Section 4(a)(1), judicial interpretations and pronouncements issued by the staff
of the SEC) then such Shares shall be issued or reissued free of all legends. The Company agrees that following the effective
date of any registration statement or at such time as such legend is no longer required under this Section 4.1(c), it will, no
later than two Trading Days following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing
restricted Shares, issued with a restrictive legend (such second Trading Day, the “Legend Removal Date”), deliver
or cause to be delivered to the Purchaser a certificate representing such Shares that is free from all restrictive and other legends.
The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions
on transfer set forth in this Section 4.1. Certificates for Shares subject to legend removal hereunder shall be transmitted by
the Transfer Agent to the Purchaser by crediting the account of the Purchaser’s prime broker with the Depository Trust Company
system as directed by the Purchaser.

 

4.2       Furnishing
of Information. After the filing of the Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 and until no Purchaser
owns Securities, the Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable
grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company
is not then subject to the reporting requirements of the Exchange Act.

 

4.3       Integration.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined
in Section 2(a)(1) of the Securities Act) that would be integrated with the offer or sale of the Shares for purposes of the rules
and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction
unless shareholder approval is obtained before the closing of such subsequent transaction.

 

4.4       Shareholder
Rights Plan. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that
any Purchaser is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the
Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and the Purchaser.

 

4.5       Use
of Proceeds. The Company shall use the net proceeds from the sale of the Securities hereunder for working capital and general
corporate purposes, and shall not use such proceeds: (a) for the satisfaction of any other portion of the Company’s debt
(other than payment of trade payables in the ordinary course of the Company’s business and prior practices), (b) for the
redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation.

 

    	 

    	 

    

 

4.6       Indemnification
of Purchaser. Subject to the provisions of this Section 4.6, the Company will indemnify and hold the Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of
a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls the Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles
notwithstanding a lack of such title or any other title) of such controlling persons (each, a “Purchaser Party”) harmless
from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments,
amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation (including local counsel,
if retained) that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations,
warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents, (b) any action
instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of
the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction
Documents (unless such action is based upon a breach of such Purchaser Party’s representations, warranties or covenants
under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or
any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which constitutes
fraud, gross negligence, willful misconduct or malfeasance) or (c) any untrue or alleged untrue statement of a material fact contained
in any registration statement, any prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary
prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein
or necessary to make the statements therein (in the case of any prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading. If any action shall be brought against any Purchaser Party in respect of which indemnity
may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall
have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any
Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment
thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time
to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material
conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the
Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel (in addition to local
counsel, if retained). The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a
Purchaser Party effected without the Company’s prior written consent, which shall not be unreasonably withheld or delayed;
or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party’s
breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in
the other Transaction Documents. The Purchaser Parties shall have the right to settle any action against any of them by the payment
of money provided that they cannot agree to any equitable relief and the Company, its officers, directors and Affiliates receive
unconditional releases in customary form. The indemnification required by this Section 4.8 shall be made by periodic payments
of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity
agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company
or others and any liabilities the Company may be subject to pursuant to law.

 

4.7       Reservation
of Common Stock. The Company agrees to reserve and keep available at all times in favor of the Purchaser on a pro rata basis
based on the Purchaser’s Subscription Amount, free of preemptive rights, a number of shares of Common Stock equal to the
number of shares of Common Stock issuable upon conversion or exercise of the Notes and Warrants, respectively (subject to adjustment
for stock splits and dividends, combinations and similar events) (the “Reserve Ratio”). The Company shall not enter
into any agreement or file any amendment to its Articles of Incorporation (including the filing of a Certificate of Designation)
which conflicts with this Section 4.7 while the Notes remain outstanding.

 

4.8       Listing
of Common Stock. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on
the Trading Market on which it is currently listed. The Company further agrees, if the Company applies to have the Common Stock
traded on any other Trading Market, it will then include in such application all of the Shares, and will take such other action
as is necessary to cause all of the Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company
will then take all action necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply
in all respects with the Company’s reporting, filing and other obligations under the bylaws or rules of the Trading Market.
The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company
or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust
Company or such other established clearing corporation in connection with such electronic transfer.

 

    	 

    	 

    

 

4.9       Certain
Transactions and Confidentiality. The Purchaser covenants that neither it nor any Affiliate acting on its behalf or pursuant
to any understanding with it will execute any purchases or sales, including Short Sales of any of the Company’s securities
during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by
this Agreement are first publicly announced. Each Purchaser covenants that until such time as the transactions contemplated by
this Agreement are publicly disclosed by the Company, the Purchaser will maintain the confidentiality of the existence and terms
of this transaction and the information included in the Disclosure Schedules. Notwithstanding the foregoing and notwithstanding
anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes
any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company
after the time that the transactions contemplated by this Agreement are first publicly announced, (ii) no Purchaser shall be restricted
or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from
and after the time that the transactions contemplated by this Agreement are first publicly announced and (iii) no Purchaser shall
have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after
the transactions contemplated by this Agreement are publicly announced. Notwithstanding the foregoing, in the case of a Purchaser
that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of the Purchaser’s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing
other portions of the Purchaser’s assets, the covenant set forth above shall only apply with respect to the portion of assets
managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.

 

4.10       Conversion
and Exercise Procedures. The form of Conversion Notice and Exercise Notice included in the Note and Warrant, respectively,
sets forth the totality of the procedures required of the Purchaser in order to convert and exercise the Note and Warrant, respectively.
No additional legal opinion, other information or instructions shall be required of the Purchaser to convert or exercise their
Notes or Warrants, respectively. Without limiting the preceding sentences, no ink-original Conversion Notice or Exercise Note
shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Conversion Notice or
Exercise Notice form be required in order to convert or exerciser the Notes or Warrants, respectively. The Company shall honor
conversions and exercises of the Notes and Warrants and shall deliver Shares in accordance with the terms, conditions and time
periods set forth in the Transaction Documents.

 

4.11       DTC
Program. For three years from the date of this Agreement, the Company will employ as the transfer agent for the Common Stock
a participant in the Depository Trust Company Automated Securities Transfer Program and cause the Common Stock to be transferable
pursuant to such program.

 

4.12       Maintenance
of Property. The Company shall keep all of its property, which is necessary or useful to the conduct of its business, in good
working order and condition, ordinary wear and tear excepted.

 

4.13       Preservation
of Corporate Existence. The Company shall preserve and maintain its corporate existence, rights, privileges and franchises
in the jurisdiction of its incorporation, and qualify and remain qualified, as a foreign corporation in each jurisdiction in which
such qualification is necessary in view of its business or operations and where the failure to qualify or remain qualified might
reasonably have a Material Adverse Effect upon the financial condition, business or operations of the Company taken as a whole.

 

ARTICLE V.

MISCELLANEOUS

 

5.1       Fees
and Expenses. Except as expressly set forth below and in the Transaction Documents to the contrary, each party shall pay the
fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party
incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer
Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the
Company and any conversion notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with
the delivery of any Securities to the Purchaser.

 

    	 

    	 

    

 

5.2       Entire
Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of
the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral
or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

 

5.3       Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered
via facsimile or email attachment at the facsimile number or email address as set forth on the signature pages attached hereto
at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such
notice or communication is delivered via facsimile or email attachment at the facsimile number or email address as set forth on
the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading
Day, (c) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service
or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications
shall be as set forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction
Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall
simultaneously file such notice with the SEC pursuant to a Current Report on Form 8-K.

 

5.4       Amendments;
Waivers. Except as provided in the last sentence of this Section 5.5, no provision of this Agreement may be waived,
modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and the Purchaser
or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought. No waiver of any default
with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future
or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay
or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any amendment effected
in accordance with accordance with this Section 5.5 shall be binding upon the Purchaser and holder of Securities and the
Company.

 

5.5       Headings.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.

 

5.6       Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted
assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of
the Purchaser (other than by merger). The Purchaser may assign any or all of its rights under this Agreement to any Person to
whom the Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect
to the transferred Securities, by the provisions of the Transaction Documents that apply to the “Purchaser.”

 

5.7       No
Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

5.8       Governing
Law; Exclusive Jurisdiction; Attorneys’ Fees. All questions concerning the construction, validity, enforcement and interpretation
of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State
of Nevada, without regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning
the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents
(whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees
or agents) shall be commenced exclusively in the state and federal courts sitting in the State of Nevada. Each party hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in the State of Nevada for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect
to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action
or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding
is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process
and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail
or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement
and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence
an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company
elsewhere in this Agreement, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party
for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution
of such Action or Proceeding.

 

    	 

    	 

    

 

5.9        Survival.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.

 

5.10       Execution.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being
understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of
the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf”
signature page were an original thereof.

 

5.11       Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid,
illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain
in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that
they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.

 

5.12       Rescission
and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of)
any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then the Purchaser
may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand
or election in whole or in part without prejudice to its future actions and rights.

 

5.13       Replacement
of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company
shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory
to the Company of such loss, theft or destruction without requiring the posting of any bond.

 

5.14       Remedies.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, the Purchaser
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages
may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents
and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy
at law would be adequate.

 

5.15       Payment
Set Aside. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or
exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from,
disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person
under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action),
then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived
and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

    	 

    	 

    

 

5.16       Liquidated
Damages. The Company’s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other
amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages
or other amounts are due and payable shall have been canceled.

 

5.17Saturdays,
Sundays, Holidays, etc.If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.

 

5.18       Construction.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction
Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting
party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and
every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after
the date of this Agreement.

 

5.19       WAIVER
OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVE FOREVER TRIAL BY JURY. 

 

5.20       Non-Circumvention.
The Company hereby covenants and agrees that the Company will not, by amendment of its Articles of Incorporation, including any
Certificates of Designation, or Bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement,
dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms of this Agreement, and will at all times in good faith carry out all of the provision of this Agreement and
take all action as may be required to protect the rights of all holders of the Securities. Without limiting the generality of
the foregoing or any other provision of this Agreement or the other Transaction Documents, the Company (a) shall not increase
the par value of any shares of Common Stock receivable upon conversion of the Notes and (b) shall take all such action as may
be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Shares upon the
conversion of the Notes.

 

(Signature Pages Follow)

 

    	 

    	 

    

 

IN WITNESS WHEREOF, the
parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as
of the date first indicated above.

 

	THERALINK
TECHNOLOGIES, inc. 

	 	Address
    for Notice:
	 	 	 
	By:	/s/
Mick Ruxin
	 	15000
W. 6th Ave., #400

	Name:	Mick
    Ruxin	 	Golden,
CO 80401

	Title:	Chief
    Executive Officer	 	Email:
    mick@theralink.com

 

With
a copy to (which shall not constitute notice):

K&L
Gates LLP

Southeast
Financial Center

200 S. Biscayne Boulevard, Suite 3900

Miami, FL 33131

Attention:
Clayton Parker

Email:
Clayton.Parker@klgates.com

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR PURCHASER FOLLOWS]

 

    	 

    	 

    

 

PURCHASER SIGNATURE PAGES TO SECURITIES PURCHASE
AGREEMENT

 

IN WITNESS WHEREOF, the
undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of
the date first indicated above.

 

Name of Purchaser: ______Ashton Capital
Corporation__ ________________________________

 

Signature of Authorized Signatory of Purchaser:
______/s/ Yvonne Fors___________________________

 

Name of Authorized Signatory: ___ _Yvonne
Fors___________________________________________

 

Title of Authorized Signatory: ______VP of
Finance__________________________________________

 

Email Address of Authorized Signatory: ________yvonnef@ashtoncorp.com_
________________________________

 

Facsimile Number of Authorized Signatory:
_________NA_____________________________

 

Address for Notice to Purchaser: 1201 Monster
Road SW Suite 350

                                Renton,
WA 98057

 

Address for Delivery of Securities to Purchaser
(if not same as address for notice):

 

Subscription Amount: $1,000,000

 

Amount of Note to be issued: $1,000,000

Amount of Warrant to be issued: 63,897,764

 

EIN Number: _______________________Exhibit
10.2

 

SECURITY
AGREEMENT

 

This
Security Agreement, dated as of May 12, 2021 (the “Agreement”) is made by and among Theralink
Technologies, Inc., a corporation duly organized and validly existing under the laws of Nevada (together with its Subsidiaries,
the “Company”), Ashton Capital Corporation and any other party who may sign a Secured Party signature
page attached hereto (each, a “Secured Party”, and collectively, the “Secured
Parties”), and Ashton Capital Corporation, as agent for the Secured Parties (in such capacity, together with
its successors in such capacity, the “Agent”).

 

WHEREAS,
pursuant to a securities purchase agreement, dated the date hereof, by and among the Company and the Purchasers signatories thereto
(the “Purchase Agreement”), the Company contemplates issuing convertible secured promissory notes,
in substantially the form attached hereto as Exhibit A (the “Notes”) to Ashton Capital Corporation
as part of the transactions contemplated by the Purchase Agreement, and all of such Notes issued pursuant to the Purchase Agreement
will be secured by first priority security interests in certain of the assets of the Company.

 

NOW
THEREFORE, in order to induce the Secured Parties to enter into the Notes, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company has agreed to pledge and grant a continuing security
interest in the Collateral (as hereinafter defined) as security for the Secured Obligations (as hereinafter defined). Accordingly,
the parties hereto agree as follows:

 

Section
1. Definitions. Each capitalized term used herein and not otherwise defined shall have the meaning assigned to
such term in the Notes or the Purchase Agreement, as applicable. In addition, as used herein:

 

“Agent”
shall mean Ashton Capital Corporation and its successors who succeed to its duties hereunder as agent for the Secured
Parties, with respect to the rights of the Secured Parties hereunder and under the other Collateral Documents.

 

“Collateral”
shall have the meaning ascribed thereto in Section 3 hereof.

 

“Event
of Default” shall have the meaning ascribed thereto in Section 3 of the Notes.

 

“Excluded
Collateral” shall mean the assets listed on Annex 2 hereto.

 

“Secured
Obligations” shall mean, collectively, the principal of and interest on the Notes issued or issuable (as applicable)
by the Company and held by the applicable Secured Party, and all other amounts from time to time owing to such Secured Parties
by the Company under this Agreement, the Purchase Agreement and the Notes.

 

“Secured
Parties” shall have the meaning defined in the preamble to this Agreement, provided that all of such parties have
purchased Notes, or other securities contemplated in the Purchase Agreement or other agreements which have been accepted and countersigned
by the Company; provided, that such term also shall include, as to the benefits, rights and obligations herein, the successors
and assigns of any Secured Party.

 

“Subsidiary”
or “Subsidiaries” of the Company shall mean any entity whose equity interests are owned entirely by the Company.

 

“Transaction
Agreements” shall mean this Agreement, the Purchase Agreement, the Notes and all ancillary documents referred to
in those agreements, and each of those agreements as may be amended.

 

    	 

    	 	 

    

 

“Uniform
Commercial Code” shall mean the Uniform Commercial Code as in effect in the State of Florida from time to time;
provided, however, that in the event that, by reason of mandatory provisions of law, any or all of the attachment, perfection,
priority, or remedies with respect to Agent’s and the Secured Parties’ lien on any Collateral is governed by the Uniform
Commercial Code as enacted and in effect in a jurisdiction other than the State of Florida, the term “Uniform Commercial
Code” shall mean the Uniform Commercial Code as enacted and in effect in such other jurisdiction solely for purposes of
the provisions thereof relating to such attachment, perfection, priority, or remedies.

 

Section
2. Representations and Warranties of the Company. The Company represents and warrants to each of the Secured Parties
that the Company is the sole beneficial owner of the Collateral and no Lien exists or will exist upon any Collateral at any time,
except for Permitted Liens and the pledge and security interest in favor of each of the Secured Parties created or provided for
herein, which pledge and security interest constitutes a first priority perfected pledge and security interest in and to all of
the Collateral.

 

Section
3. Collateral. As collateral security for the prompt payment in full when due (whether at stated maturity, by acceleration
or otherwise) of the Secured Obligations, the Company hereby acknowledges, agrees and confirms that (i) Agent, on behalf of the
Secured Parties as hereinafter provided, shall continue to have a security interest in and lien upon and, (ii) to the extent not
otherwise previously granted to Agent, Company hereby pledges, grants, assigns, hypothecates and transfers to the Agent, on behalf
of the Secured Parties as hereinafter provided, a first priority security interest in and lien upon all of the Company’s
laboratory equipment set forth on Annex 2, except for the Excluded Collateral (all of the foregoing except the Excluded
Collateral being collectively referred to herein as “Collateral”).

 

Section
4. Further Assurances; Remedies. In furtherance of the grant of the pledge and security interest pursuant to Section
3 hereof, the Company hereby agrees with the Agent and each of the Secured Parties as follows:

 

4.01
Delivery and Other Perfection. The Company shall:

 

	 	a.	give,
    execute, deliver, file and record any financing statement, notice, instrument, document, agreement or other papers that may
    be necessary or desirable (in the reasonable judgment of the Agent) to create, preserve, maintain, perfect or validate any
    security interest previously granted or granted pursuant hereto or to enable the Agent to exercise and enforce its rights
    hereunder with respect to such security interest, including, without limitation, upon the occurrence and continuance of an
    Event of Default, causing any or all of the Collateral to be transferred of record into the name of the Agent or its nominee;
	 	 	 
	 	b.	keep
    accurate books and records relating to the Collateral, and stamp or otherwise mark such books and records in such manner as
    the Agent may reasonably require in order to reflect the security interests granted by this Agreement; and
	 	 	 
	 	c.	permit
    representatives of the Agent, upon reasonable notice, at any time during normal business hours to inspect and make abstracts
    from its books and records pertaining to the Collateral, and permit representatives of the Agent to be present at the Company’s
    place of business to receive copies of all communications and remittances relating to the Collateral, and forward copies of
    any notices or communications by the Company with respect to the Collateral, all in such manner as the Agent may reasonably
    require.

 

    	 	2	Security Agreement

    	 	 

    

 

4.02
Other Financing Statements and Liens. Except with respect to liens in connection with any Senior Indebtedness
or as otherwise permitted under the Notes or the Purchase Agreement, without the prior written consent of the Agent, the Company
shall not file or suffer to be on file, or authorize or permit to be filed or to be on file, in any jurisdiction, any financing
statement or like instrument with respect to the Collateral in which the Agent is not named as the sole secured party for the
benefit of each of the Secured Parties.

 

4.03
Events of Default, etc. Upon the occurrence and during the continuation of an Event of Default, the Agent may,
and at the request of the Secured Parties (acting together) shall, exercise any or all of the following rights and remedies:

 

	 	a.	require
    the Company to (and, upon such request, the Company shall) assemble and make available to the Agent the Collateral and all
    books and records relating thereto at such place or places, reasonably requested by the Agent, whether at the Company’s
    premises or elsewhere;
	 	 	 
	 	b.	the
    Agent may make any reasonable compromise or settlement deemed desirable with respect to any of the Collateral and may extend
    the time of payment, arrange for payment in installments, or otherwise modify the terms of, any of the Collateral;
	 	 	 
	 	c.	the
    Agent shall have all of the rights and remedies with respect to the Collateral of a secured party under the Uniform Commercial
    Code (whether or not said Code is in effect in the jurisdiction where the rights and remedies are asserted) and such additional
    rights and remedies to which a secured party is entitled under the laws in effect in any jurisdiction where any rights and
    remedies hereunder may be asserted, including, without limitation, the right, to the maximum extent permitted by law, to exercise
    all voting, consensual and other powers of ownership pertaining to the Collateral as if the Agent were the sole and absolute
    owner thereof (and the Company agrees to take all such action as may be appropriate to give effect to such right);
	 	 	 
	 	d.	the
    Agent in its discretion may, in its name or in the name of the Company or otherwise, demand, sue for, collect or receive any
    money or property at any time payable or receivable on account of or in exchange for any of the Collateral, but shall be under
    no obligation to do so; and
	 	 	 
	 	e.	the
    Agent may, upon ten (10) days’ prior written notice to the Company of the time and place, with respect to the Collateral
    or any part thereof which shall then be or shall thereafter come into the possession, custody or control of the Agent, or
    any of its respective agents, sell, lease, assign or otherwise dispose of all or any of such Collateral, at such place or
    places as the Agent deems best, and for cash or on credit or for future delivery (without thereby assuming any credit risk),
    at public or private sale, without demand of performance or notice of intention to effect any such disposition or of time
    or place thereof (except such notice as is required above or by applicable statute and cannot be waived) and the Agent or
    anyone else may be the purchaser, lessee, assignee or recipient of any or all of the Collateral so disposed of at any public
    sale (or, to the extent permitted by law, at any private sale), and thereafter hold the same absolutely, free from any claim
    or right of whatsoever kind, including any right or equity of redemption (statutory or otherwise), of the Company, any such
    demand, notice or right and equity being hereby expressly waived and released. The Agent may, without notice or publication,
    adjourn any public or private sale or cause the same to be adjourned from time to time by announcement at the time and place
    fixed for the sale, and such sale may be made at any time or place to which the same may be so adjourned.

 

    	 	3	Security Agreement

    	 	 

    

 

The
proceeds of each collection, sale or other disposition under this Section 4.03, shall be applied in accordance with Section 4.06
hereof.

 

4.04
Deficiency. If the proceeds of sale, collection or other realization of or upon the Collateral pursuant to Section
4.03 hereof are insufficient to cover the costs and expenses of such realization and the payment in full of the Secured Obligations,
the Company shall remain liable for any deficiency.

 

4.05
Removals, etc. Without at least thirty (30) days’ prior written notice to the Agent or unless otherwise
required by law, the Company shall not (i) maintain any of its books or records with respect to the Collateral at any office or
maintain its chief executive office or its principal place of business at any place, or permit any Collateral to be located anywhere
other than at one of the locations identified in Annex 3 hereto or in transit from one of such locations to another;
or (ii) change its corporate name, or the name under which it does business, from the name shown on the signature page hereto.

 

4.06
Application of Proceeds. Except as otherwise herein expressly provided, the proceeds of any collection, sale
or other realization of all or any part of the Collateral pursuant hereto, and any other cash at the time held by the Agent under
this Section 4, shall be applied by the Agent:

 

First,
to the payment of the costs and expenses of such collection, sale or other realization, including reasonable out-of-pocket
costs and expenses of the Agent and the fees and expenses of its agents and counsel, and all expenses, and advances made or incurred
by the Agent in connection therewith;

 

Next,
to the payment in full of the Secured Obligations in each case equally and ratably in accordance with the respective amounts
thereof then due and owing to each of the Secured Parties; and

 

Finally,
to the payment to the Company, or its successors or assigns, or as a court of competent jurisdiction may direct, of any surplus
then remaining.

 

As
used in this Section 4, “proceeds” of Collateral shall mean cash, securities and other property realized
in respect of, and distributions in kind of, Collateral, including any thereof received under any reorganization, liquidation
or adjustment of debt of the Company or any issuer of or obligor on any of the Collateral.

 

4.07
Attorney-in-Fact. Without limiting any rights or powers granted by this Agreement to the Agent while no Event
of Default has occurred and is continuing, upon the occurrence and during the continuance of any Event of Default, the Agent is
hereby appointed the attorney-in-fact of the Company for the purpose of carrying out the provisions of this Section 4 and taking
any action and executing any instruments which the Agent may deem necessary or advisable to accomplish the purposes hereof, which
appointment as attorney-in-fact is irrevocable and coupled with an interest. Without limiting the generality of the foregoing,
so long as the Secured Parties shall be entitled under this Section 4 to make collections in respect of the Collateral, the Agent
shall have the right and power to receive, endorse and collect all checks made payable to the order of the Company representing
any dividend, payment, or other distribution in respect of the Collateral or any part thereof and to give full discharge for the
same.

 

    	 	4	Security Agreement

    	 	 

    

 

4.08
Perfection. Prior to or concurrently with the execution and delivery of this Agreement, the Company shall file
such financing statements and other documents in such offices as may be necessary (including any such offices as the Agent may
request) to perfect or maintain the security interests granted by Section 3 of this Agreement; and without limiting the Company’s
obligations with respect to perfection of the security interests, the Company hereby authorizes the Agent to file all such financing
statements and other documents (and ratifies any previously filed financing statements and other documents filed by the Agent
on behalf of the Secured Parties) on behalf of the Secured Parties.

 

4.09
Termination. When all Secured Obligations shall have been paid in full under each of the Notes, this Agreement
shall terminate, and the Agent shall forthwith cause to be assigned, transferred and delivered, against receipt but without any
recourse, warranty or representation whatsoever, any remaining Collateral and money received in respect thereof, to or on the
order of the Company and to be released and cancelled all licenses and rights referred to in Section 4.03(a)(1) hereof. The Agent
shall also execute and deliver to the Company upon such termination such Uniform Commercial Code termination statements and such
other documentation as shall be reasonably requested by the Company, at the Company’s expense, to effect the termination
and release of the liens on the Collateral.

 

4.10
Expenses. The Company agrees to pay to the Agent all out-of-pocket expenses (including reasonable expenses for
legal services of every kind) of, or incident to, the enforcement of any of the provisions of this Section 4, or performance by
the Agent of any obligations of the Company in respect of the Collateral which the Company has failed or refused to perform upon
reasonable notice, or any actual or attempted sale, or any exchange, enforcement, collection, compromise or settlement in respect
of any of the Collateral, and for the care of the Collateral and defending or asserting rights and claims of the Agent in respect
thereof, by litigation or otherwise, including expenses of insurance, and all such expenses shall be Secured Obligations to the
Agent secured under Section 3 hereof. Each Secured Party agrees to advance to the Agent his/her/it’s pro rata share of any
funds requested by the Agent to carry out the intent and purposes of this Agreement according to each Secured Party’s pro
rata share of the total aggregate principal amount outstanding under the Notes at the time such request for advance is made. Any
such advances will be refunded to the Secured Parties to the extent the Company reimburses the Agent for its expenses or the Agent
makes recoveries from the disposition of the Company’s assets, in each case, similarly in such Secured Party’s pro
rata share.

 

4.11
Further Assurances. The Company agrees that, from time to time upon the written request of the Agent, the Company
will execute and deliver such further documents and do such other acts and things as the Agent may reasonably request in order
fully to effect the purposes of this Agreement.

 

4.12
Subordination. The Secured Parties agree that all payments on account of the Secured Obligations shall be subordinated
and subject in right of payment, to the extent and manner set forth herein, to the prior payment in full in cash or cash equivalents
of any existing or future Senior Indebtedness of the Company. “Senior Indebtedness” shall mean any (i) indebtedness,
liabilities and other obligations of the Company or with respect to which the Company is a guarantor, to banks, insurance companies
or other lending or thrift institutions regularly engaged in the business of lending money, whether or not secured, (ii) indebtedness,
liabilities and other obligations of the Company under any line of credit or revolving credit facility and (iii) any deferrals,
renewals or extensions or any debentures, notes or other evidence of indebtedness issued in exchange for such Senior Indebtedness.
Upon request from the Company, each Secured Party will agree to execute and deliver a subordination agreement and/or an intercreditor
agreement, in a form reasonably acceptable to any banks, insurance companies or other lending or thrift institutions holding Senior
Indebtedness, subordinating the Secured Party’s interests in the Collateral to the interests of any banks, insurance companies
or other lending or thrift institutions holding Senior Indebtedness. Upon any receivership, insolvency, assignment for the benefit
of creditors, bankruptcy, reorganization, or arrangement which creditors (whether or not pursuant to bankruptcy or other insolvency
laws), sale of all or substantially all of the assets, dissolution, liquidation, or any other marshaling of the assets and liabilities
of the Company or in the event the Notes shall be due and payable (including upon maturity), (i) no amount shall be paid by the
Company, whether in cash or property in respect of the principal of or interest on the Notes at the time outstanding, unless and
until the full amount of any Senior Indebtedness then outstanding shall be paid in full, and (ii) no claim or proof of claim shall
be filed with the Company by or on behalf of the Secured Parties which shall assert any right to receive any payments in respect
of the principal of and interest on the Notes except subject to the payment in full all of the Senior Indebtedness then outstanding.
If an event of default has occurred with respect to any Senior Indebtedness, permitting the holder thereof to accelerate the maturity
thereof, then unless and until such event of default shall have been cured or waived or shall have ceased to exist, or all Senior
Indebtedness shall have been paid in full, no payment shall be made in respect of the principal of or interest on the Notes and
no action shall be taken with respect to the Collateral

 

    	 	5	Security Agreement

    	 	 

    

 

Section
5. The Agent

 

5.01
Appointment of Agent. Each Secured Party agrees to appoint Ashton Capital Corporation as its Agent for purposes
of this Agreement. Each of Secured Party hereby authorizes the Agent to take such action and to exercise such powers hereunder
as provided herein or therein or as requested to or consented by the Secured Parties (acting together), together with such powers
as are reasonably incidental thereto. Subject to the provisions of this Agreement, the Agent will not take any action contrary
to the express written instructions of the Secured Parties (acting together) and will take any lawful action prescribed in express
written instructions of the Secured Parties (acting together). The provisions of this Section 5 are solely for the benefit of
the Agent and the Secured Parties, and the Borrower shall have no rights as a third party beneficiary of any such provisions.
The Agent may decline to take any action except upon the express written instructions of the Secured Parties (acting together)
and the Agent may request a written ratification by the Secured Parties (acting together) of any action taken by it under this
Agreement, which ratification shall not be unreasonably withheld, conditioned or delayed. The Agent shall not be obligated to
take any action, or engage in any course of conduct, if the Secured Parties are not in agreement as to such action or course of
conduct. The Agent may employ agents and attorneys-in-fact in connection herewith and shall not be responsible for the negligence
or misconduct of any such agents or attorneys-in-fact selected by it in good faith.

 

5.02
Powers and Duties. Subject to and upon the other terms and conditions contained herein that limit the
obligations or duties of the Agent, the duties and obligations of the Agent under this Agreement shall be those of a “collateral
agent” and shall consist of and be limited to: (i) acquiring, holding and enforcing the security interest granted by the
Company in the Collateral; (ii) selling, releasing, surrendering, realizing upon or otherwise dealing with, in any manner and
in any order, all or any portion of the Collateral, (iii) exercising (or refraining from exercising) any rights, remedies or powers
of the Agent under this Agreement, or under applicable law in respect of all or any portion of the Collateral, (iv) making any
demands or giving any notices hereunder, and (v) effecting amendments to or granting waivers or consents hereunder (as approved
by the Secured Parties).

 

5.03
Resignation and Removal. The Agent shall be entitled to resign at any time upon written notice to the Secured
Parties. Except as provided above, upon any such resignation, the Secured Parties shall have the right to appoint a successor
Agent by the vote of the Secured Parties holding a majority of the outstanding principal amounts of the Secured Obligations secured
by a pledge of the Collateral. If no successor Agent shall have been so appointed by such Secured Parties, and shall have accepted
such appointment, within thirty (30) days after the retiring Agent’s giving of notice of resignation, then the retiring
Agent may, on behalf of the Secured Parties, appoint a successor Agent. Upon the acceptance of any appointment as the Agent hereunder
by a successor Agent, such successor Agent shall thereupon succeed to and become vested with all the rights, powers, privileges
and duties of the retiring Agent, and the retiring Agent shall be discharged from its duties and obligations as the Agent under
this Agreement. After any retiring or the Agent’s resignation hereunder as the Agent, the provisions of Sections 5.01 through
5.05 shall inure to its benefit as to any actions taken or omitted to be taken by it while it was the Agent under this Agreement.

 

    	 	6	Security Agreement

    	 	 

    

 

5.04
Indemnity of Agent. Each of the Secured Parties severally agrees to indemnify the Agent in its capacity as such
(to the extent not reimbursed by the Borrower and without limiting the obligation of the Borrower to do so), ratably according
to its total aggregate principal amount outstanding under its Notes at the time of the event that gave rise to such reimbursement
or indemnity claim by the Agent under this Section 5.04 (or, if indemnification is sought after the date upon which all the Secured
Obligations shall have been paid in full, ratably in accordance with the total aggregate principal amount outstanding under its
Notes immediately prior to such date), from and against any and all claims, actions, judgments, damages, losses, liabilities,
costs and expenses or disbursements of any kind whatsoever (including, without limitation, reasonable attorneys’ fees and
expenses) that may be imposed on, incurred by or asserted against the Agent in any way relating to or arising out of this Agreement
or any transactions contemplated hereby or thereby or any action taken or omitted by such Agent under or in connection with the
foregoing; provided that no Secured Party shall be liable for the payment of any claims, actions, judgments, damages, losses,
liabilities, costs and expenses or disbursements that are found by a court of competent jurisdiction to have resulted from the
Agent’s gross negligence, bad faith or willful misconduct or as a result of the Agent’s breach of its obligations
hereunder.

 

5.05
Compensation of Agent. The Agent shall not be entitled to any compensation for its duties as Agent unless all
of the Secured Parties have consented to such compensation.

 

5.06
Right to Realize on Collateral. Anything contained in any of the Transaction Agreements to the contrary
notwithstanding, the Borrower, the Agent and each Secured Party hereby agree that no Secured Party shall have any right individually
to realize upon any of the Collateral, it being understood and agreed that all powers, rights and remedies hereunder and under
any of the Transaction Agreements may be exercised solely by the Agent, for the benefit of the Secured Parties in accordance with
the terms hereof and thereof.

 

Section
6. Miscellaneous.

 

6.01
No Waiver. No failure on the part of the Agent or any of its agents to exercise, and no course of dealing with
respect to, and no delay in exercising, any right, power or remedy hereunder shall operate as a waiver thereof; nor shall any
single or partial exercise by the Agent or any of its agents of any right, power or remedy hereunder preclude any other or further
exercise thereof or the exercise of any other right, power or remedy. The remedies herein are cumulative and are not exclusive
of any remedies provided by law.

 

6.02
Governing Law. This Agreement shall be governed by, and construed in accordance with, the law of the State of
Colorado.

 

6.03
Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted
hereunder shall be in writing and, unless otherwise specified herein, shall be (a) personally served, (b) deposited in the mail,
registered or certified, return receipt requested, postage prepaid, (c) delivered by reputable air courier service with charges
prepaid, or (d) transmitted by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address as
such party shall have specified most recently by written notice given in accordance herewith. Any notice or other communication
required or permitted to be given hereunder shall be deemed effective (i) upon hand delivery or delivery by facsimile, with accurate
confirmation generated by the transmitting facsimile machine, at the address or number designated below (if delivered on a business
day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered
other than on a business day during normal business hours where such notice is to be received) or (ii) on the second business
day following the date of mailing by express courier service or on the fifth business day after deposited in the mail, in each
case, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses
for such communications shall be for (i) the Company at 15000 W. 6th Ave., #400, Golden, CO 80401, Telephone: 888-585-4923, (ii)
the Agent at 1201 Monster Road SW, Suite 350, Renton, WA 98057, and (iii) for each Secured Party as provided on the signature
page hereto. Any party hereto may from time to time change its address or facsimile number for notices under this Section by written
notice to the other parties.

 

    	 	7	Security Agreement

    	 	 

    

 

6.04
Waivers, etc. The terms of this Agreement may be waived, altered or amended only by an instrument in writing
duly executed by the Company and the Agent. Any such amendment or waiver shall be binding upon each of the Secured Parties and
the Company.

 

6.05
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the respective successors
and assigns of the Company and each of the Secured Parties (provided, however, that the Company shall not assign or transfer its
rights hereunder without the prior written consent of the Agent (acting on the approval of each of the Secured Parties).

 

6.06
Counterparts; Additional Secured Parties. This Agreement may be executed in any number of counterparts, all
of which together shall constitute one and the same instrument and any of the parties hereto may execute this Agreement by signing
any such counterpart. In the event additional Secured Parties become holders of the Notes, such Secured Parties will become a
party to this Agreement by signing a counterpart to this Agreement in a form reasonably acceptable to the Agent, all of which
together shall be considered one and the same instrument. The Company shall provide a copy of each counterpart to this Agreement
executed by a Secured Party to the Agent.

 

6.07
Severability. If any provision hereof is invalid and unenforceable in any jurisdiction, then, to the fullest
extent permitted by law, (i) the other provisions hereof shall remain in full force and effect in such jurisdiction and shall
be liberally construed in favor of the Secured Parties in order to carry out the intentions of the parties hereto as nearly as
may be possible and (ii) the invalidity or unenforceability of any provision hereof in any jurisdiction shall not affect the validity
or enforceability of such provision in any other jurisdiction.

 

6.08
Entire Agreement. This Agreement (together which each Annex hereto) and the other Transaction Agreements contains
the entire agreement and understanding by and between the parties hereto with respect to the subject matter hereof and their resulting
obligations to each other, as herein described; and it amends, restates and supersedes all prior agreements and understandings
between the parties to this Agreement relating to the subject matter hereof. No change or modification of this Agreement shall
be valid or binding unless the same is in writing and signed by the party intended to be so bound. No waiver of any provision
of this Agreement shall be valid unless the same is in writing and signed by the party against whom such waiver is sought to be
enforced. Moreover, no valid waiver of any provision of this Agreement, at any time, shall be deemed to be a waiver of any other
provision of this Agreement at such time, or shall be deemed to be a valid waiver of such provision at any other time.

 

[The
remainder of this page intentionally left blank.]

 

    	 	8	Security Agreement

    	 	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Security Agreement to be duly executed as of the day and year first above
written.

 

	The
                                            “Company”:

	 	The
                                            “Agent”:

	 	 	 	 	 
	THERALINK
                                            TECHNOLOGIES, inc

	 	Ashton
                                            Capital Corporation

	 	 	 	 
	By:	/s/ Mick
    Ruxin

        
	 	By:	

        
/s/ Yvonne Fors
	Name:	Mick
                                            Ruxin

        
	 	Name:	Yvonne
                                            Fors

        

	Title:	Chief
                                            Executive Officer
	 	Title:	VP
                                            of Finance

        

 

    	 

    	 	 

    

 

SECURITY
AGREEMENT

 

SECURED
PARTY SIGNATURE PAGE

 

IN
WITNESS WHEREOF, the undersigned Secured Party agrees to the terms and conditions of the above Security Agreement and hereby agrees
that the execution of this Secured Party Signature Page is intended and shall be deemed to constitute the execution of such Security
Agreement by the undersigned.

 

	Ashton
    Capital Corporation	 
	 	 	 
	By:
    	/s/ Yvonne
    Fors	 
	Name:	Yvonne
    Fors	 
	Title:
    	VP
    of Finance	 

 

Address
for Notices:

 

1201
Monster Road SW Suite 350

 

Renton,
WA 98057

 

Phone:
206-575-8436

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}]]